Pazopanib plus cetuximab in recurrent or metastatic head and neck squamous cell carcinoma: an open-label, phase 1b and expansion study

Douglas Adkins; Paul Mehan; Jessica Ley; Marilyn J. Siegel; Barry A. Siegel; Farrokh Dehdashti; Xuntian Jiang; Noha N. Salama; Kathryn Trinkaus; Peter Oppelt

doi:10.1016/S1470-2045(18)30350-4

Pazopanib plus cetuximab in recurrent or metastatic head and neck squamous cell carcinoma: an open-label, phase 1b and expansion study

Douglas Adkins, Paul Mehan, Jessica Ley, Marilyn J. Siegel, Barry A. Siegel, Farrokh Dehdashti, Xuntian Jiang, Noha N. Salama, Kathryn Trinkaus, Peter Oppelt

Pharmaceutical and Administrative Sciences Department

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1082-1093
Number of pages	12
Journal	The Lancet Oncology
Volume	19
Issue number	8
DOIs	https://doi.org/10.1016/S1470-2045(18)30350-4
State	Published - Aug 2018

ASJC Scopus Subject Areas

Oncology

Access to Document

10.1016/S1470-2045(18)30350-4

Cite this

@article{55d6d691fd584a7ca22688dad059f186,

title = "Pazopanib plus cetuximab in recurrent or metastatic head and neck squamous cell carcinoma: an open-label, phase 1b and expansion study",

author = "Douglas Adkins and Paul Mehan and Jessica Ley and Siegel, {Marilyn J.} and Siegel, {Barry A.} and Farrokh Dehdashti and Xuntian Jiang and Salama, {Noha N.} and Kathryn Trinkaus and Peter Oppelt",

note = "Publisher Copyright: {\textcopyright} 2018 Elsevier Ltd",

year = "2018",

month = aug,

doi = "10.1016/S1470-2045(18)30350-4",

language = "English",

volume = "19",

pages = "1082--1093",

journal = "The Lancet Oncology",

issn = "1470-2045",

number = "8",

}

TY - JOUR

T1 - Pazopanib plus cetuximab in recurrent or metastatic head and neck squamous cell carcinoma

T2 - an open-label, phase 1b and expansion study

AU - Adkins, Douglas

AU - Mehan, Paul

AU - Ley, Jessica

AU - Siegel, Marilyn J.

AU - Siegel, Barry A.

AU - Dehdashti, Farrokh

AU - Jiang, Xuntian

AU - Salama, Noha N.

AU - Trinkaus, Kathryn

AU - Oppelt, Peter

PY - 2018/8

Y1 - 2018/8

UR - http://www.scopus.com/inward/record.url?scp=85053822311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053822311&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(18)30350-4

DO - 10.1016/S1470-2045(18)30350-4

M3 - Article

C2 - 30001987

AN - SCOPUS:85053822311

SN - 1470-2045

VL - 19

SP - 1082

EP - 1093

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 8

ER -

Pazopanib plus cetuximab in recurrent or metastatic head and neck squamous cell carcinoma: an open-label, phase 1b and expansion study

ASJC Scopus Subject Areas

Access to Document

Other files and links

Cite this